Jae-Yoon Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jae-Yoon Kim has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- YoungRok Choi
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
29 shared publications - Kwang-Woong Lee
Department of Surgery, Seoul National University Hospital, Seoul, Korea
28 shared publications - Suk Kyun Hong
Department of Surgery, Seoul National University Hospital, Seoul, Korea
24 shared publications - Su Young Hong
Department of Surgery, Seoul National University Hospital, Seoul, Korea
22 shared publications - Jiyoung Kim
Department of Surgery Seoul National University College of Medicine Seoul South Korea
20 shared publications - Kyung-Suk Suh
Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea
20 shared publications
Latest Publications
- 14 October 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1103
Robotic cholecystectomy using da Vinci SP, single-site, and multiport systems: a systematic review and comparative meta-analysis
Robotic platform names do not specify operative access or instrumentation. We compared da Vinci SP, Single-Site, and multiport cholecystectomy, prioritizing total operative time and planned-access completion failure. Five databases were searched in August 2026, with Scopus rerun on 6 October 2026. A registered review underwent outcome-specific, publication-based adjudication. Direct robot-to-robot mean differences were synthesized using restricted maximum likelihood (REML) and modified Hartung–Knapp confidence intervals (CIs). Single-incision laparoscopic cholecystectomy (SILC) comparisons were ancillary; historical indirect calculations were confined to a supplementary audit. Fourteen reports were included; nine supplied extractable direct data from analysis samples totaling 1,542 participants. For SP versus Single-Site, total operative time was very uncertain (4 studies; 580 participants; mean difference [MD] − 12.49 min; 95% CI − 36.50 to 11.53; I² = 91.0%), including one conditionally reconstructed mean. The full planned-access completion-failure composite was not estimable. Console time was secondary (4 studies; 580 participants; MD − 11.40 min; modified Hartung–Knapp 95% CI − 25.35 to 2.56; I² = 80.4%; approximate 95% prediction interval − 49.03 to 26.24). Its conventional REML–Wald CI excluded zero (− 19.43 to − 3.36), but the small-study-adjusted interval did not. Rare-event safety, long-term hernia, cost-effectiveness, and platform-specific workload evidence were insufficient. The evidence is very uncertain about differences in total operative and console time between da Vinci SP and Single-Site cholecystectomy. An overall operative-time advantage or comparative safety equivalence has not been established. The evidence does not isolate the causal effects of incision count and articulation. Review registration: PROSPERO CRD420261475321.
- 14 October 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1103
Robotic cholecystectomy using da Vinci SP, single-site, and multiport systems: a systematic review and comparative meta-analysis
Robotic platform names do not specify operative access or instrumentation. We compared da Vinci SP, Single-Site, and multiport cholecystectomy, prioritizing total operative time and planned-access completion failure. Five databases were searched in August 2026, with Scopus rerun on 6 October 2026. A registered review underwent outcome-specific, publication-based adjudication. Direct robot-to-robot mean differences were synthesized using restricted maximum likelihood (REML) and modified Hartung–Knapp confidence intervals (CIs). Single-incision laparoscopic cholecystectomy (SILC) comparisons were ancillary; historical indirect calculations were confined to a supplementary audit. Fourteen reports were included; nine supplied extractable direct data from analysis samples totaling 1,542 participants. For SP versus Single-Site, total operative time was very uncertain (4 studies; 580 participants; mean difference [MD] − 12.49 min; 95% CI − 36.50 to 11.53; I² = 91.0%), including one conditionally reconstructed mean. The full planned-access completion-failure composite was not estimable. Console time was secondary (4 studies; 580 participants; MD − 11.40 min; modified Hartung–Knapp 95% CI − 25.35 to 2.56; I² = 80.4%; approximate 95% prediction interval − 49.03 to 26.24). Its conventional REML–Wald CI excluded zero (− 19.43 to − 3.36), but the small-study-adjusted interval did not. Rare-event safety, long-term hernia, cost-effectiveness, and platform-specific workload evidence were insufficient. The evidence is very uncertain about differences in total operative and console time between da Vinci SP and Single-Site cholecystectomy. An overall operative-time advantage or comparative safety equivalence has not been established. The evidence does not isolate the causal effects of incision count and articulation. Review registration: PROSPERO CRD420261475321.
- 7 October 2026
- Published by Wolters Kluwer Health in Liver Transplantation
Robotic recipient surgery in living donor liver transplantation: A single-center consecutive case series
Was not provided for this article.
- 7 October 2026
- Published by Wolters Kluwer Health in Liver Transplantation
Robotic recipient surgery in living donor liver transplantation: A single-center consecutive case series
Was not provided for this article.
- Open Access
- 9 April 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
Impact of allocation priority for children awaiting liver transplantation in Korea: a pediatric liver allocation simulated model analysis
Jaewon Lee, YoungRok Choi, Nam-Joon Yi, Kyung Chul Yoon, Jiyoung Kim, Jae-Yoon Kim, Hyun Hwa Choi, Sola Lee, Su young Hong, Suk Kyun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0062
- 9 April 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
Open AccessImpact of allocation priority for children awaiting liver transplantation in Korea: a pediatric liver allocation simulated model analysis
Jaewon Lee, YoungRok Choi, Nam-Joon Yi, Kyung Chul Yoon, Jiyoung Kim, Jae-Yoon Kim, Hyun Hwa Choi, Sola Lee, Su young Hong, Suk Kyun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0062
- Open Access
- 12 February 2026
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 6 (1) , 33-40
Rapamycin mitigates warm ischemia-induced peribiliary fibrosis: A non-transplant experimental model with implications for ischemic cholangiopathy
Hyun Hwa Choi, Geun Hong, Kwang-Woong Lee, Jae-Yoon Kim, Jiyoung Kim, Jaewon Lee, Su Young Hong, Suk Kyun Hong, YoungRok Choi. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.25.0022
- 12 February 2026
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 6 (1) , 33-40
Open AccessRapamycin mitigates warm ischemia-induced peribiliary fibrosis: A non-transplant experimental model with implications for ischemic cholangiopathy
Hyun Hwa Choi, Geun Hong, Kwang-Woong Lee, Jae-Yoon Kim, Jiyoung Kim, Jaewon Lee, Su Young Hong, Suk Kyun Hong, YoungRok Choi. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.25.0022
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (4) , 194-202
Prognostic significance of indocyanine green fluorescence patterns in resected hepatocellular carcinoma: a retrospective analysis of prospectively collected data
Ahn HW, et al. Ann Surg Treat Res. 2026 Oct;111(4):194-202. https://doi.org/10.4174/astr.2026.111.4.194
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (4) , 194-202
Open AccessPrognostic significance of indocyanine green fluorescence patterns in resected hepatocellular carcinoma: a retrospective analysis of prospectively collected data
Ahn HW, et al. Ann Surg Treat Res. 2026 Oct;111(4):194-202. https://doi.org/10.4174/astr.2026.111.4.194
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (1) , 24-32
Laparoscopic versus open liver resection following transarterial radioembolization for hepatocellular carcinoma: a retrospective propensity score-matched study
Sng YP, et al. Ann Surg Treat Res. 2026 Jul;111(1):24-32. https://doi.org/10.4174/astr.2026.111.1.24
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (1) , 24-32
Open AccessLaparoscopic versus open liver resection following transarterial radioembolization for hepatocellular carcinoma: a retrospective propensity score-matched study
Sng YP, et al. Ann Surg Treat Res. 2026 Jul;111(1):24-32. https://doi.org/10.4174/astr.2026.111.1.24
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (6) , 366-373
Anatomical risk stratification for major portal vein complications in dual portal vein living donor liver transplantation: a retrospective cohort study
Choi HH, et al. Ann Surg Treat Res. 2026 Jun;110(6):366-373. https://doi.org/10.4174/astr.2026.110.6.366
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (6) , 366-373
Open AccessAnatomical risk stratification for major portal vein complications in dual portal vein living donor liver transplantation: a retrospective cohort study
Choi HH, et al. Ann Surg Treat Res. 2026 Jun;110(6):366-373. https://doi.org/10.4174/astr.2026.110.6.366
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (4) , 273-280
Effect of weight reduction on liver volume in living liver donors with steatosis: a retrospective cohort study
Hong K, et al. Ann Surg Treat Res. 2026 Apr;110(4):273-280. https://doi.org/10.4174/astr.2026.110.4.273
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (4) , 273-280
Open AccessEffect of weight reduction on liver volume in living liver donors with steatosis: a retrospective cohort study
Hong K, et al. Ann Surg Treat Res. 2026 Apr;110(4):273-280. https://doi.org/10.4174/astr.2026.110.4.273
- Open Access
- 30 October 2025
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 5 (2) , 89-97
Evaluating a 3D-printed biodegradable paclitaxel-eluting stent for biliary stricture management after liver transplantation: An in vivo porcine study
Jiyoung Kim, YoungRok Choi, Joon Koo Han, Jae Hyun Kim, Dong-Heon Ha, Eui Soo Han, Jiwon Koh, Jae-Yoon Kim, Jaewon Lee, Hyun Hwa Choi, Su young Hong, Jeong-Moo Lee, Suk Kyun Hong, Kwang-Woong Lee. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.25.0013
- 30 October 2025
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 5 (2) , 89-97
Open AccessEvaluating a 3D-printed biodegradable paclitaxel-eluting stent for biliary stricture management after liver transplantation: An in vivo porcine study
Jiyoung Kim, YoungRok Choi, Joon Koo Han, Jae Hyun Kim, Dong-Heon Ha, Eui Soo Han, Jiwon Koh, Jae-Yoon Kim, Jaewon Lee, Hyun Hwa Choi, Su young Hong, Jeong-Moo Lee, Suk Kyun Hong, Kwang-Woong Lee. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.25.0013
- 12 September 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (9) , e70314
Integrating Alpha‐Fetoprotein and Protein Induced by Vitamin K Antagonist‐II as Surveillance Tools After Liver Transplantation for Hepatocellular Carcinoma: A Novel Protocol for Early Detection of Tumor Recurrence
Hepatocellular carcinoma (HCC) is a cancer prevalent worldwide, and liver transplantation (LT) is a curative treatment option. However, post‐transplantation recurrence remains a significant concern, necessitating the identification of predictive factors and early detection of patients with recurrence. Alpha‐fetoprotein (AFP) and proteins induced by vitamin K absence‐II (PIVKA‐II) are recognized HCC diagnostic markers. However, standardized protocols for testing intervals and supplemental imaging incorporation are limited. This study explored the integration of both tumor markers as surveillance tools and suggested different surveillance protocols based on recurrence risk. We conducted a retrospective analysis of 708 patients who underwent living donor liver transplantation (LDLT) for HCC. Patients were categorized into four groups based on models for tumor recurrence after liver transplantation (MoRAL) scores and tumor marker normalization after LT. Group 1, with the lowest risk, showed 12.5% recurrence at 15 months, whereas Group 4 showed 96.2% recurrence within 5 months. Integrating AFP and PIVKA‐II yielded an overall 82% sensitivity for recurrence detection. As 28.0% of patients with HCC recurrence in Group 1 revealed recurrence without tumor marker elevation, we propose a novel HCC surveillance protocol with differentiated intervals based on specific risk groups. This approach is promising for enhancing early detection and post‐transplantation outcomes.
- 12 September 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (9) , e70314
Integrating Alpha‐Fetoprotein and Protein Induced by Vitamin K Antagonist‐II as Surveillance Tools After Liver Transplantation for Hepatocellular Carcinoma: A Novel Protocol for Early Detection of Tumor Recurrence
Hepatocellular carcinoma (HCC) is a cancer prevalent worldwide, and liver transplantation (LT) is a curative treatment option. However, post‐transplantation recurrence remains a significant concern, necessitating the identification of predictive factors and early detection of patients with recurrence. Alpha‐fetoprotein (AFP) and proteins induced by vitamin K absence‐II (PIVKA‐II) are recognized HCC diagnostic markers. However, standardized protocols for testing intervals and supplemental imaging incorporation are limited. This study explored the integration of both tumor markers as surveillance tools and suggested different surveillance protocols based on recurrence risk. We conducted a retrospective analysis of 708 patients who underwent living donor liver transplantation (LDLT) for HCC. Patients were categorized into four groups based on models for tumor recurrence after liver transplantation (MoRAL) scores and tumor marker normalization after LT. Group 1, with the lowest risk, showed 12.5% recurrence at 15 months, whereas Group 4 showed 96.2% recurrence within 5 months. Integrating AFP and PIVKA‐II yielded an overall 82% sensitivity for recurrence detection. As 28.0% of patients with HCC recurrence in Group 1 revealed recurrence without tumor marker elevation, we propose a novel HCC surveillance protocol with differentiated intervals based on specific risk groups. This approach is promising for enhancing early detection and post‐transplantation outcomes.